【透云生物(01332.HK)发布年度业绩,股东应占亏损8810.7万港元 同比减少67.24%】透云生物(01332.HK)发布截至2024年12月31日止年度业绩,该集团取得销售所提供货品及服务的收入1.52亿港元,同比减少23.09%;公司拥有人应占亏损8810.7万港元,同比减少67.24%;每股亏损3.14港仙。

金融界
26 Mar
透云生物(01332.HK)发布截至2024年12月31日止年度业绩,该集团取得销售所提供货品及服务的收入1.52亿港元,同比减少23.09%;公司拥有人应占亏损8810.7万港元,同比减少67.24%;每股亏损3.14港仙。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10